MTHFR and Cognitive impairment: Previous studies suggest that MTHFR genotype appears not to significantly influence the age of onset, clinical phenotype, or prognosis in patients with cblC deficiency, although further investigation is warranted to clarify potential interactions.[14] Interestingly, the phenomenon of recurrent cognitive impairment and venous sinus thrombosis has not been previously documented in the context of MMA.